Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$79.4 - $116.36 $291,795 - $427,623
-3,675 Reduced 10.82%
30,280 $2.42 Million
Q1 2022

Apr 07, 2022

BUY
$86.42 - $109.81 $1.13 Million - $1.43 Million
13,050 Added 62.43%
33,955 $3.57 Million
Q4 2021

Jan 13, 2022

BUY
$98.56 - $119.91 $2.06 Million - $2.51 Million
20,905 New
20,905 $2.25 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Abner Herrman & Brock LLC Portfolio

Follow Abner Herrman & Brock LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.